Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Omeros Corp (NASDAQ:OMER)

20.80
Delayed Data
As of Aug 21
 -1.23 / -5.58%
Today’s Change
7.20
Today|||52-Week Range
27.09
+109.68%
Year-to-Date
No recent news for Omeros Corp.

Today’s Trading

Previous close22.03
Today’s open22.17
Day’s range20.37 - 22.18
Volume1,223,133
Average volume (3 months)924,824
Market cap$1.0B
Dividend yield--
Data as of 08/21/2017

Growth & Valuation

Earnings growth (last year)+17.50%
Earnings growth (this year)+16.87%
Earnings growth (next 5 years)+85.00%
Revenue growth (last year)+208.07%
P/E ratioNM
Price/Sales9.64
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BHVNBiohaven Pharmaceuti...+1.81+6.35%
ACORAcorda Therapeutics ...-0.05-0.23%
DVAXDynavax Technologies...-0.35-2.16%
AIMTAimmune Therapeutics...+0.18+0.94%
Data as of 08/21/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$41.6M
Annual profit (last year)-$66.7M
Net profit margin-160.38%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gregory A. Demopulos
CFO, Treasurer, Chief Accounting Officer &
VP
Michael A. Jacobsen
Corporate headquarters
Seattle, Washington

Forecasts